The RNA-Seq of in vivo ibrutinib-exposed CLL cells revealed FoxO1 induction (Figure 2A), and this attracted our attention, since FoxO1 has been shown to transcriptionally activate Rictor in renal cancer cells (35). Here, FOXO1 is linked to renal carcinoma.